RAYDENT SW
RAY Co., Ltd. is listed for RAYDENT SW (K233625). The FDA list gives May 16, 2024 as the date of the final decision. The lead panel is Dental, and the database link on the FDA list is the 510(k) pathway. openFDA describes product code PNN as “Orthodontic Software”: The device is software that is to be used for the diagnosis and treatment planning of orthodontic patients and conditions. It may include orthodontic output devices used for the treatment of orthodontics. The device is intended for prescription use only. openFDA records this submission’s decision description as “Substantially Equivalent.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K233625
- Date of final decision
- May 16, 2024
- Company on the FDA list
- RAY Co., Ltd.
- Lead panel
- Dental
- Primary product code
- PNN
- openFDA device name for the code
- Orthodontic Software
- Device class
- 2
- Regulation number
- 872.5470
- openFDA decision description
- Substantially Equivalent
- openFDA decision code
- SESE
- Statement or summary label
- Summary
Product-code text from openFDA
The device is software that is to be used for the diagnosis and treatment planning of orthodontic patients and conditions. It may include orthodontic output devices used for the treatment of orthodontics. The device is intended for prescription use only.